Evolutionary Diversity and Developmental Regulation of X-chromosome Inactivation
Affiliations
X-chromosome inactivation (XCI) results in the transcriptional silencing of one X-chromosome in females to attain gene dosage parity between XX female and XY male mammals. Mammals appear to have developed rather diverse strategies to initiate XCI in early development. In placental mammals XCI depends on the regulatory noncoding RNA X-inactive specific transcript (Xist), which is absent in marsupials and monotremes. Surprisingly, even placental mammals show differences in the initiation of XCI in terms of Xist regulation and the timing to acquire dosage compensation. Despite this, all placental mammals achieve chromosome-wide gene silencing at some point in development, and this is maintained by epigenetic marks such as chromatin modifications and DNA methylation. In this review, we will summarise recent findings concerning the events that occur downstream of Xist RNA coating of the inactive X-chromosome (Xi) to ensure its heterochromatinization and the maintenance of the inactive state in the mouse and highlight similarities and differences between mammals.
Oncogenes and tumor suppressor genes: functions and roles in cancers.
Dakal T, Dhabhai B, Pant A, Moar K, Chaudhary K, Yadav V MedComm (2020). 2024; 5(6):e582.
PMID: 38827026 PMC: 11141506. DOI: 10.1002/mco2.582.
Validation of a DNA methylation microarray for 285,000 CpG sites in the mouse genome.
Garcia-Prieto C, Alvarez-Errico D, Musulen E, Bueno-Costa A, Vazquez B, Vaquero A Epigenetics. 2022; 17(12):1677-1685.
PMID: 35297293 PMC: 9621044. DOI: 10.1080/15592294.2022.2053816.
The Molecular and Nuclear Dynamics of X-Chromosome Inactivation.
Dossin F, Heard E Cold Spring Harb Perspect Biol. 2021; 14(4).
PMID: 34312245 PMC: 9121902. DOI: 10.1101/cshperspect.a040196.
New Insights into X-Chromosome Reactivation during Reprogramming to Pluripotency.
Panda A, Zylicz J, Pasque V Cells. 2020; 9(12).
PMID: 33348832 PMC: 7766869. DOI: 10.3390/cells9122706.
The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient.
Li Y, Li T, Tang Y, Zhan Z, Ding L, Song L PLoS One. 2020; 15(6):e0234262.
PMID: 32516327 PMC: 7282642. DOI: 10.1371/journal.pone.0234262.